174 related articles for article (PubMed ID: 34980342)
1. [Olmesartan-associated Enteropathy].
Zou L; Wang Q; Li Y; Yang AM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Dec; 43(6):986-990. PubMed ID: 34980342
[TBL] [Abstract][Full Text] [Related]
2. Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.
Choi EY; McKenna BJ
Arch Pathol Lab Med; 2015 Oct; 139(10):1242-7. PubMed ID: 26414468
[TBL] [Abstract][Full Text] [Related]
3. Olmesartan-associated Enteropathy with Acute Kidney Injury.
Kang MJ; Min KH; Kim HW; Park SB; Kang DH; Choi CW; Kim SJ; Nam HS; Ryu DG
Korean J Gastroenterol; 2022 Mar; 79(3):130-134. PubMed ID: 35342171
[TBL] [Abstract][Full Text] [Related]
4. [Olmesartan-associated enteropathy: attention to an emerging iatrogenic phenomenon].
Modesto Dos Santos JL; González Recio P; Terry López OA; Leturia Frade I; Aguiar Losada B; Elejalde Guerra JI
An Sist Sanit Navar; 2017 Aug; 40(2):291-294. PubMed ID: 28676728
[TBL] [Abstract][Full Text] [Related]
5. Olmesartan-induced enteropathy treated with budesonide.
Kempenaers S; Bogaert J; De Maeyer M; Van Hauthem P; Ramael M; Schoeters P
Acta Gastroenterol Belg; 2019; 82(2):319-321. PubMed ID: 31314195
[TBL] [Abstract][Full Text] [Related]
6. [Olmesartan therapy and enteropathy: About two cases and review of the literature].
Sadki A; Le Besnerais M; Héron F; Marie I
Rev Med Interne; 2019 Feb; 40(2):112-116. PubMed ID: 30174111
[TBL] [Abstract][Full Text] [Related]
7. Association of sprue-like enteropathy and angiotensin receptor-1 antagonists.
Wenzel RR; Datz C
Wien Klin Wochenschr; 2019 Oct; 131(19-20):493-501. PubMed ID: 31471672
[TBL] [Abstract][Full Text] [Related]
8. Olmesartan-Induced Enteropathy.
Adike A; Corral J; Rybnicek D; Sussman D; Shah S; Quigley E
Methodist Debakey Cardiovasc J; 2016; 12(4):230-232. PubMed ID: 28289500
[TBL] [Abstract][Full Text] [Related]
9. [Three cases of severe chronic diarrhea with a rare cause and a simple therapy].
Rommel KP; Schneider E; Witschel I; Halm U; Zachäus M
Internist (Berl); 2018 Sep; 59(9):961-966. PubMed ID: 29637237
[TBL] [Abstract][Full Text] [Related]
10. Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study.
You SC; Park H; Yoon D; Park S; Joung B; Park RW
Korean J Intern Med; 2019 Jan; 34(1):90-98. PubMed ID: 29172402
[TBL] [Abstract][Full Text] [Related]
11. Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture.
Abbruzzi F; Loconte I; Carparelli S; Ierardi E; Di Leo A; Principi M
Curr Drug Saf; 2020; 15(1):65-68. PubMed ID: 31549594
[TBL] [Abstract][Full Text] [Related]
12. An atypical case of chronic diarrhoea: olmesartan-induced sprue-like enteropathy.
Naik DK; Martelli MG; Gonzalo DH; Sharma AK; Pannu D
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370634
[TBL] [Abstract][Full Text] [Related]
13. Olmesartan-induced enteropathy.
Onteddu NK; Pulivarthi VSKK; Ginnavaram M; Kedika R
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30279248
[TBL] [Abstract][Full Text] [Related]
14. Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology.
Burbure N; Lebwohl B; Arguelles-Grande C; Green PH; Bhagat G; Lagana S
Hum Pathol; 2016 Apr; 50():127-34. PubMed ID: 26997446
[TBL] [Abstract][Full Text] [Related]
15. Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study.
Basson M; Mezzarobba M; Weill A; Ricordeau P; Allemand H; Alla F; Carbonnel F
Gut; 2016 Oct; 65(10):1664-9. PubMed ID: 26250345
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced enteropathy.
Marietta EV; Cartee A; Rishi A; Murray JA
Dig Dis; 2015; 33(2):215-220. PubMed ID: 25925925
[TBL] [Abstract][Full Text] [Related]
17. Sprue-like enteropathy due to olmesartan.
Muñoz-Muñoz C; López-Vivancos J; Huaman W; García-Cors M
Rev Esp Enferm Dig; 2015 Oct; 107(10):647-8. PubMed ID: 26437988
[TBL] [Abstract][Full Text] [Related]
18. Pharmacy and therapeutics committees strategy to address olmesartan safety issues at a primary care level.
Rovira-Illamola M; Pagès-Puigdemont N; Sotoca-Momblona JM; Mensa-Vendrell M; Barba-Ávila O; Casasayas-Guilera M
Int J Clin Pharm; 2020 Apr; 42(2):737-743. PubMed ID: 32078107
[TBL] [Abstract][Full Text] [Related]
19. Case report: Confirming a diagnosis of severe olmesartan-associated enteropathy.
Roulet L; Bedatsova L; Merz L; Desmeules J; Saiah L
Therapie; 2023; 78(3):338-342. PubMed ID: 35907681
[No Abstract] [Full Text] [Related]
20. A Rare Case of Olmesartan-Associated Enteropathy Successfully Managed With Steroid Taper.
Xue A; Fowler MR; Silverman J; Sturkie E; Raff E
Cureus; 2023 Jul; 15(7):e41604. PubMed ID: 37559845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
